A carregar...
Cancer immunotherapy‐targeted glypican‐3 or neoantigens
Immune checkpoint inhibitors have ushered in a new era in cancer therapy, although other therapies or combinations thereof are still needed for many patients for whom these drugs are ineffective. In this light, we have identified glypican‐3 an HLA‐24, HLA‐A2 restriction peptide with extreme cancer s...
Na minha lista:
| Publicado no: | Cancer Sci |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5834776/ https://ncbi.nlm.nih.gov/pubmed/29285841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13485 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|